Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization
about
sameAs
Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivoThe activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitorAssembly of adherens junctions is required for sphingosine 1-phosphate-induced matriptase accumulation and activation at mammary epithelial cell-cell contactsGene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasisProtein interaction analysis of ST14 domains and their point and deletion mutants.Serine 254 enhances an induced fit mechanism in murine 5-aminolevulinate synthase.What we know about ST13, a co-factor of heat shock protein, or a tumor suppressor?Effect of SNC19/ST14 gene overexpression on invasion of colorectal cancer cells.Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesisX-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2).ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines.The molecular and clinical impact of hepatocyte growth factor, its receptor, activators, and inhibitors in wound healing.Transmembrane serine protease TADG-15 (ST14/Matriptase/MT-SP1): expression and prognostic value in ovarian cancer.ST14 (suppression of tumorigenicity 14) gene is a target for miR-27b, and the inhibitory effect of ST14 on cell growth is independent of miR-27b regulationA Nonsense Variant in the ST14 Gene in Akhal-Teke Horses with Naked Foal Syndrome.Mechanisms of hepatocyte growth factor activation in cancer tissues.Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.The tumor suppressor role of PAQR3 in osteosarcoma.Requirement of the activity of hepatocyte growth factor activator inhibitor type 1 for the extracellular appearance of a transmembrane serine protease matriptase in monkey kidney COS-1 cells.Quantitation of membrane type serine protease 1 (MT-SP1) in transformed and normal cells.Identification of the matriptase second CUB domain as the secondary site for interaction with hepatocyte growth factor activator inhibitor type-1.Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity.Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.Expression of serine protease matriptase in renal cell carcinoma: correlation of tissue microarray immunohistochemical expression analysis results with clinicopathological parameters.
P2860
Q24672921-80DC7982-DBA9-4D28-90F8-6BC02733E493Q28203364-46E4C617-B8DA-49CC-AE28-FBCB824738B4Q28255706-75A8D501-F656-4A45-BC3B-2C619CB38AD7Q33210156-511BC29D-B29D-4B27-A03D-A581EE148270Q33231437-3F8C38BF-484B-45B6-AD41-5DD473E42985Q33661662-2C4ACB9B-0B70-40ED-AF3A-F4BB898A489AQ35663665-4E0EE0F2-D12C-40CA-AC1D-FFA48CB0695DQ35784079-EC46BCB7-D682-4E42-9ECE-871AB834956BQ35790323-80047D66-C433-4887-860C-95DCF30DA9BCQ35823094-D0A076A5-5F19-458D-BD5C-CE4153924DE1Q36217252-EA40A986-6850-4782-B30B-1CC1A2F90735Q36386270-030963E0-E0B2-4A0A-B6AE-6573FBCD3274Q36395707-5CA350FA-F8A6-48A7-8DF3-4E55F780A0D4Q36616173-5443E2DB-C896-4463-9BFE-58FA15DDD4FFQ37371739-09624939-A045-4F96-A569-13DC768FF525Q37746507-31336DF9-8E5F-4A77-AE96-940CD2E0ECC1Q38255480-076EA553-C5AC-45E6-A1BE-C29A6213AE02Q38771773-4B6979B4-A24C-44AB-8ADD-DC6C54C44AE5Q38928368-E8A7BB76-8DBF-454F-A922-AE7AD2D1A7EAQ39816749-F6C28AD6-AD01-46DB-BC84-3A1B26D2FF3CQ40658561-2F805C6E-C8BC-489F-A343-049AC0C10B5DQ42399102-7EBAD308-ACC9-4B7A-8A68-C4D1077BBC49Q46846863-6100710C-6519-4E44-AA02-927615C1EFCCQ46913912-44737AD9-EC99-4600-ABFA-41D20C85577DQ46963498-E2EC055A-4C7D-4363-B0B8-8D477EE03C6C
P2860
Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and ST14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization
description
1998 nî lūn-bûn
@nan
1998 թուականին հրատարակուած գիտական յօդուած
@hyw
1998 թվականին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Assignment1 of human putative ...... ->q25 by in situ hybridization
@ast
Assignment1 of human putative ...... ->q25 by in situ hybridization
@en
Assignment1 of human putative ...... ->q25 by in situ hybridization
@nl
type
label
Assignment1 of human putative ...... ->q25 by in situ hybridization
@ast
Assignment1 of human putative ...... ->q25 by in situ hybridization
@en
Assignment1 of human putative ...... ->q25 by in situ hybridization
@nl
altLabel
Assignment1 of human putative ...... 4→q25 by in situ hybridization
@ast
Assignment1 of human putative ...... 4→q25 by in situ hybridization
@en
prefLabel
Assignment1 of human putative ...... ->q25 by in situ hybridization
@ast
Assignment1 of human putative ...... ->q25 by in situ hybridization
@en
Assignment1 of human putative ...... ->q25 by in situ hybridization
@nl
P2093
P3181
P356
P1476
Assignment1 of human putative ...... ->q25 by in situ hybridization
@en
Assignment1 of human putative ...... 4→q25 by in situ hybridization
@en
P2093
B Schlegelberger
B. Schlegelberger
P3181
P356
10.1159/000015125
P407
P577
1998-01-01T00:00:00Z
1999-02-01T00:00:00Z